NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pin Therapeutics

Pin Therapeutics

Private
South KoreaHealthcare & Life Scienceshttps://pintherapeutics.com/

Last Round

Series C

Dec 23, 2024

Est. Valuation

$83.86M

Total Funding Raised

$55.46M

Company Overview

Pin Therapeutics is a biotechnology company that develops therapeutic drugs using targeted protein degradation technology to treat diseases like cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

targeted protein degradationTPDsmall-molecule drugsdrug discoveryoncology researchprotein degradersundruggable targetsbiotechdrug developmentchemoinformaticsdegrader discoverypharma partnershipsprotein degradationPROTACs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pin Therapeutics Comparables

Compare Pin Therapeutics with similar companies based on industry and business-model similarity.

Pin Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cyrus Therapeutics
91%
UPPTHERA
89%
Ubix Therapeutics
86%

Pin Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 23, 2024
DebtFeb 1, 2023
Series BFeb 21, 2022
DebtMar 1, 2021
Series AAug 28, 2019
Pre Seed
Nov 1, 2017

Key People

Founding team and executive leadership

신창섭Changsup Shin

CFO

Executive Team

Pin Therapeutics Investors

Notable investors and investment history

Pin Therapeutics investors
InvestorRounds
KDB Capital CorpSeries C
CKD Venture CapitalSeries C
DSC InvestmentSeries B, Series C, Debt
KB InvestmentSeries B, Series C, Debt
Korea Investment PartnersSeries B, Series C, Debt
KB InvestmentSeries B, Series C, Debt
Company K PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2021

    Raised $13M from DSC Investment and Honest Ventures.

  • Aug 28, 2019

    $5M round led by K-Run Ventures and SJ Investment Partners.

Pin Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pin Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pin Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range16
Year Founded2017
Last FundingDec 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.